Gilbert, R. E., & Connelly, K. A. (2019). Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: Evident and plausible. Cardiovasc Diabetol.
Citação norma ChicagoGilbert, Richard E., and Kim A. Connelly. "Reduction in the Incidence of Myocardial Infarction With Sodium–glucose Linked Cotransporter-2 Inhibitors: Evident and Plausible." Cardiovasc Diabetol 2019.
Deismireacht MLAGilbert, Richard E., and Kim A. Connelly. "Reduction in the Incidence of Myocardial Infarction With Sodium–glucose Linked Cotransporter-2 Inhibitors: Evident and Plausible." Cardiovasc Diabetol 2019.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.